Skip to main content
Caplight Logo









Medivis

Medivis

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.medivis.com/

Last Round

Series A

Jun 13, 2023

Total Funding Raised

$22.3M

Company Overview

Medivis is a healthtech company that provides an augmented reality and artificial intelligence platform to advance medical imaging and surgical navigation.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, AR/VR Experiences, Medical Devices

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

augmented reality surgerysurgical visualizationmedical ARsurgical navigationholographic surgerymedical image segmentationsurgical planningdigital surgeryFDA-cleared softwareDICOM visualizationAI-powered surgerysurgical techoperating room softwaremedical device softwareAR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medivis Comparables

Compare Medivis with similar companies based on industry and business-model similarity.

Medivis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Surgical Theater
86%
MediView XR, Inc.
86%
apoQlar GmbH
83%

Medivis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 13, 2023
SeedFeb 12, 2019

Medivis Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2025

    Received FDA clearance for Spine Navigation product.

  • Apr 2, 2025

    Spine Navigation product now available nationwide.

Medivis Filings

Explore SEC and related filing metadata, where available.

Medivis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medivis's valuation, stock price, and market status.

Is Medivis a public or private company?

Medivis is a private company.

What is the current stock price of Medivis?

Medivis is a private company with no public stock price. No recent secondary market data is available.

How much is Medivis worth (valuation)?

Valuation information for Medivis is not publicly available.

Can I buy Medivis stock?

Medivis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medivis's last funding round?

Medivis's most recent funding round was Series A on June 13, 2023.

Who are the main investors in Medivis?

Key investors in Medivis include Thrive Capital.

Will Medivis IPO soon?

No public IPO plans have been announced for Medivis.

How can I track Medivis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medivis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range29
Year Founded2016
Last FundingJun 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?